280 results
Page 3 of 14
8-K
EX-2.1
cuk7p8
24 Jan 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
zwuteeas0njt6hrb9ro5
29 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
utp2r nrqhen
29 Nov 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.15
muf0t nqsbzvl3cwn8
27 May 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
brriqcofd5yau6dc6
9 Nov 09
Results of Operations and Financial Condition
12:00am
8-K
EX-10.1
fup0sv5k6jv2hx9ndh
14 Jan 08
Entry into a Material Definitive Agreement
12:00am
8-K
gc95wsulk5uar
25 Sep 20
Entry into a Material Definitive Agreement
5:25pm
PRE 14C
epun lxd52j
18 Jul 06
Preliminary information
12:00am
8-K
EX-10.3
rvf63dzknz9c9
17 Dec 13
GeoVax Announces $1.65M Private Placement
12:00am
8-K
EX-10.1
fxuhxk 9yp7b
31 Jul 07
GEOVAX SIGNS A $7.5 MILLION PRIVATE PLACEMENT AGREEMENT Investment Supports GeoVax AIDS Vaccine Development
12:00am
PRER14C
daqne25b
8 Aug 06
Preliminary revised information
12:00am
8-K
EX-10.3
fzl7qnd
2 Mar 15
Funds to be Used to Advance the Company’s Innovative Vaccine Technology
12:00am
8-K
EX-10.4
jpgwa32om26wira0k
26 Jun 20
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-10.4
5yxwyvdf6 9lbjes6rih
2 Mar 15
Funds to be Used to Advance the Company’s Innovative Vaccine Technology
12:00am
8-K
EX-10.6
foayyq 1q0r4khkr
2 Mar 15
Funds to be Used to Advance the Company’s Innovative Vaccine Technology
12:00am
8-K
EX-99
jq9w583
19 Jun 97
Acquisition or disposition of assets
12:00am
8-K
EX-10.5
876 v6lcr
2 Mar 15
Funds to be Used to Advance the Company’s Innovative Vaccine Technology
12:00am